Quantcast

Latest Hypolipidemic agent Stories

2011-06-06 16:42:00

NEW YORK, June 6, 2011 /PRNewswire/ -- According to research presented by Dr. David B. Samadi, a prostate cancer treatment, robotic prostatectomy, and prostate surgery expert, at the annual meeting of the American Urological Association men taking statins, a class of widely used cholesterol-lowering drugs, have significantly lower serum PSA (prostate-specific antigen) levels than their non statin-using counterparts. (Photo: http://photos.prnewswire.com/prnh/20110606/NY14928 ) This PSA...

b636c65c31fd06af473ad0b6327660cb
2011-05-27 08:25:00

U.S. government researchers said on Thursday that giving a high dose of niacin to people with heart disease who are already taking a cholesterol-lowering statin does nothing more to prevent heart attacks and strokes. The findings challenge the notion that raising high-density lipoprotein (HDL) can further reduce heart risks in people who already have their low-density lipoprotein (LDL) under control. Patients in the study who had a history of heart disease were treated with Abbott...

2011-05-19 16:23:00

ABBOTT PARK, Ill., May 19, 2011 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of the ACCORD Lipid study as they relate to the use of fenofibric acid (sold as Trilipix® in the United States) in combination with a statin in patients with mixed dyslipidemia and at high risk of heart disease. In response to the Committee's majority recommendation to retain the Trilipix...

2011-05-04 06:15:00

HOERSHOLM, Denmark and SAN DIEGO, May 4, 2011 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that it has advanced SPC5001 into Phase 1 clinical trials for the treatment of high cholesterol. SPC5001 is a mRNA-targeted drug that inhibits the exciting new target, Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9), a protein involved in removing low density...

2011-04-26 14:35:51

Cholesterol-lowering drugs known as statins may help clot-busting drugs treat strokes, according to researchers at Washington University School of Medicine in St. Louis. The research involved 31 patients with ischemic stroke, a disorder when a clot blocks blood flow to part of the brain. In 12 patients who were already taking statins to control their cholesterol, blood flow returned to the blocked areas of the brain more completely and quickly. "We've known that patients on statins have...

2011-04-12 07:15:00

CLEVELAND, April 12, 2011 /PRNewswire/ -- Neuroendocrinology Letters has just published a paper by the Dzugan Institute of Restorative Medicine entitled "Correction of steroidopenia as a new method of hypercholesterolemia treatment." In this study, Principle Investigator Sergey Dzugan, M.D., Ph.D., demonstrates that "correction of steroidopenia with anthropo-identical hormones" (bio-identical hormone restorative therapy or HT) can be an inexpensive and effective method of treatment for high...

2011-04-05 14:28:17

LSHTM study finds evidence for protective effect of cholesterol-lowering medication Taking statins could help prevent people dying from pneumonia, according to a study by the London School of Hygiene and Tropical Medicine. The researchers found that the risk of death in the six month period after diagnosis of pneumonia was substantially lower among those who were already receiving the cholesterol-lowering drugs compared with those who were not. Previous studies have suggested that statins may...

2011-01-21 08:14:09

(Ivanhoe Newswire) -- Cardiovascular disease (CVD) is the most common cause of death, accounting for one-third of the deaths worldwide. According to a new study, there isn't enough evidence to promote the use of statins (cholesterol-lowering drugs) in people with no previous history of heart disease. Researchers believe statins should be prescribed with caution to those at low risk of CVD. Statins are first line treatments for heart patients, and the benefits are certain, according to the...

2011-01-18 22:23:43

Researchers have determined the structure and mechanism of an enzyme that performs the crucial first step in the formation of cholesterol and a key virulence factor in staph bacteria. Chemists at the University of Illinois and collaborators in Taiwan studied a type of enzyme found in humans, plants, fungi, parasites, and many bacteria that begins the synthesis of triterpenes "“ one of the most abundant and most ancient classes of molecules. Triterpenes are precursors to steroids such as...

2010-12-06 07:00:00

HAIKOU CITY, China, Dec. 6, 2010 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced the completion of clinical trials of the cholesterol-lowering drug, rosuvastatin (generic version of Crestor), which the Company intends to commercialize in the large and expanding Chinese healthcare market. Rosuvastatin helps reduce low-density lipoprotein...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related